DR ING HC F PORSCHE AG (P911.DE) Fundamental Analysis & Valuation

FRA:P911 • DE000PAG9113

37.85 EUR
-0.79 (-2.04%)
Last: Mar 6, 2026, 07:00 PM

This P911.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

Overall P911 gets a fundamental rating of 5 out of 10. We evaluated P911 against 31 industry peers in the Automobiles industry. While P911 belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. P911 is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

8

1. P911.DE Profitability Analysis

1.1 Basic Checks

  • In the past year P911 was profitable.
  • In the past year P911 had a positive cash flow from operations.
  • In the past 5 years P911 has always been profitable.
  • In the past 5 years P911 always reported a positive cash flow from operatings.
P911.DE Yearly Net Income VS EBIT VS OCF VS FCFP911.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

1.2 Ratios

  • P911 has a better Return On Assets (3.88%) than 83.87% of its industry peers.
  • P911 has a better Return On Equity (9.19%) than 83.87% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 6.83%, P911 belongs to the top of the industry, outperforming 80.65% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for P911 is significantly above the industry average of 5.95%.
  • The last Return On Invested Capital (6.83%) for P911 is well below the 3 year average (13.25%), which needs to be investigated, but indicates that P911 had better years and this may not be a problem.
Industry RankSector Rank
ROA 3.88%
ROE 9.19%
ROIC 6.83%
ROA(3y)9.11%
ROA(5y)8.43%
ROE(3y)22.84%
ROE(5y)20.35%
ROIC(3y)13.25%
ROIC(5y)11.73%
P911.DE Yearly ROA, ROE, ROICP911.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

  • P911's Profit Margin of 3.69% is fine compared to the rest of the industry. P911 outperforms 74.19% of its industry peers.
  • P911's Profit Margin has declined in the last couple of years.
  • P911 has a better Operating Margin (6.64%) than 77.42% of its industry peers.
  • In the last couple of years the Operating Margin of P911 has declined.
  • The Gross Margin of P911 (18.85%) is better than 61.29% of its industry peers.
  • P911's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 6.64%
PM (TTM) 3.69%
GM 18.85%
OM growth 3Y-3.68%
OM growth 5Y-1.89%
PM growth 3Y-9.69%
PM growth 5Y-1.78%
GM growth 3Y-0.89%
GM growth 5Y0.39%
P911.DE Yearly Profit, Operating, Gross MarginsP911.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

5

2. P911.DE Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), P911 is creating value.
  • The number of shares outstanding for P911 remains at a similar level compared to 1 year ago.
  • P911 has about the same amout of shares outstanding than it did 5 years ago.
  • The debt/assets ratio for P911 is higher compared to a year ago.
P911.DE Yearly Shares OutstandingP911.DE Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
P911.DE Yearly Total Debt VS Total AssetsP911.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.2 Solvency

  • P911 has a debt to FCF ratio of 5.28. This is a neutral value as P911 would need 5.28 years to pay back of all of its debts.
  • P911 has a better Debt to FCF ratio (5.28) than 80.65% of its industry peers.
  • A Debt/Equity ratio of 0.29 indicates that P911 is not too dependend on debt financing.
  • P911 has a better Debt to Equity ratio (0.29) than 83.87% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 5.28
Altman-Z N/A
ROIC/WACC1.12
WACC6.08%
P911.DE Yearly LT Debt VS Equity VS FCFP911.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.3 Liquidity

  • P911 has a Current Ratio of 1.35. This is a normal value and indicates that P911 is financially healthy and should not expect problems in meeting its short term obligations.
  • With a decent Current ratio value of 1.35, P911 is doing good in the industry, outperforming 77.42% of the companies in the same industry.
  • A Quick Ratio of 0.96 indicates that P911 may have some problems paying its short term obligations.
  • The Quick ratio of P911 (0.96) is better than 64.52% of its industry peers.
Industry RankSector Rank
Current Ratio 1.35
Quick Ratio 0.96
P911.DE Yearly Current Assets VS Current LiabilitesP911.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2

3. P911.DE Growth Analysis

3.1 Past

  • The earnings per share for P911 have decreased strongly by -30.27% in the last year.
  • P911 shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.12% yearly.
  • Looking at the last year, P911 shows a decrease in Revenue. The Revenue has decreased by -1.10% in the last year.
  • P911 shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.05% yearly.
EPS 1Y (TTM)-30.27%
EPS 3Y-3.83%
EPS 5Y5.12%
EPS Q2Q%-198.51%
Revenue 1Y (TTM)-1.1%
Revenue growth 3Y6.55%
Revenue growth 5Y7.05%
Sales Q2Q%-4.39%

3.2 Future

  • Based on estimates for the next years, P911 will show a decrease in Earnings Per Share. The EPS will decrease by -2.28% on average per year.
  • The Revenue is expected to grow by 3.18% on average over the next years.
EPS Next Y-83.94%
EPS Next 2Y-22.77%
EPS Next 3Y-10.58%
EPS Next 5Y-2.28%
Revenue Next Year-6.14%
Revenue Next 2Y-2.84%
Revenue Next 3Y-1.13%
Revenue Next 5Y3.18%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
P911.DE Yearly Revenue VS EstimatesP911.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 10B 20B 30B 40B 50B
P911.DE Yearly EPS VS EstimatesP911.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1 2 3 4 5

6

4. P911.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 9.61, which indicates a very decent valuation of P911.
  • P911's Price/Earnings ratio is a bit cheaper when compared to the industry. P911 is cheaper than 74.19% of the companies in the same industry.
  • P911's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.29.
  • The Price/Forward Earnings ratio is 16.11, which indicates a correct valuation of P911.
  • P911's Price/Forward Earnings ratio is in line with the industry average.
  • The average S&P500 Price/Forward Earnings ratio is at 24.57. P911 is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 9.61
Fwd PE 16.11
P911.DE Price Earnings VS Forward Price EarningsP911.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, P911 is valued cheaply inside the industry as 93.55% of the companies are valued more expensively.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of P911 indicates a somewhat cheap valuation: P911 is cheaper than 77.42% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 7.97
EV/EBITDA 1.07
P911.DE Per share dataP911.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

  • The excellent profitability rating of P911 may justify a higher PE ratio.
  • P911's earnings are expected to decrease with -10.58% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)1.88
EPS Next 2Y-22.77%
EPS Next 3Y-10.58%

4

5. P911.DE Dividend Analysis

5.1 Amount

  • P911 has a Yearly Dividend Yield of 5.58%, which is a nice return.
  • The stock price of P911 dropped by -21.03% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
  • Compared to an average industry Dividend Yield of 3.07, P911 pays a bit more dividend than its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.82, P911 pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.58%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years2
P911.DE Yearly Dividends per shareP911.DE Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

  • P911 pays out 100.96% of its income as dividend. This is not a sustainable payout ratio.
DP100.96%
EPS Next 2Y-22.77%
EPS Next 3Y-10.58%
P911.DE Yearly Income VS Free CF VS DividendP911.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B
P911.DE Dividend Payout.P911.DE Dividend Payout, showing the Payout Ratio.P911.DE Dividend Payout.PayoutRetained Earnings

P911.DE Fundamentals: All Metrics, Ratios and Statistics

DR ING HC F PORSCHE AG

FRA:P911 (3/6/2026, 7:00:00 PM)

37.85

-0.79 (-2.04%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)10-10
Earnings (Next)03-11
Inst Owners11.43%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap17.24B
Revenue(TTM)56.35B
Net Income(TTM)2.08B
Analysts52.73
Price Target45.8 (21%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.58%
Yearly Dividend2.31
Dividend Growth(5Y)N/A
DP100.96%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-98.95%
Min EPS beat(2)-263.81%
Max EPS beat(2)65.91%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-5.24%
Min Revenue beat(2)-9.69%
Max Revenue beat(2)-0.79%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.05%
PT rev (3m)-0.84%
EPS NQ rev (1m)0%
EPS NQ rev (3m)38.36%
EPS NY rev (1m)0%
EPS NY rev (3m)-13.32%
Revenue NQ rev (1m)2.38%
Revenue NQ rev (3m)1.17%
Revenue NY rev (1m)-0.15%
Revenue NY rev (3m)-0.4%
Valuation
Industry RankSector Rank
PE 9.61
Fwd PE 16.11
P/S 0.31
P/FCF 7.97
P/OCF 3.56
P/B 0.76
P/tB 1.19
EV/EBITDA 1.07
EPS(TTM)3.94
EY10.41%
EPS(NY)2.35
Fwd EY6.21%
FCF(TTM)4.75
FCFY12.55%
OCF(TTM)10.64
OCFY28.11%
SpS123.71
BVpS49.69
TBVpS31.71
PEG (NY)N/A
PEG (5Y)1.88
Graham Number66.37
Profitability
Industry RankSector Rank
ROA 3.88%
ROE 9.19%
ROCE 9.85%
ROIC 6.83%
ROICexc 10.13%
ROICexgc 14.89%
OM 6.64%
PM (TTM) 3.69%
GM 18.85%
FCFM 3.84%
ROA(3y)9.11%
ROA(5y)8.43%
ROE(3y)22.84%
ROE(5y)20.35%
ROIC(3y)13.25%
ROIC(5y)11.73%
ROICexc(3y)18.5%
ROICexc(5y)16.21%
ROICexgc(3y)27.68%
ROICexgc(5y)23.14%
ROCE(3y)19.1%
ROCE(5y)16.92%
ROICexgc growth 3Y2.85%
ROICexgc growth 5Y3.55%
ROICexc growth 3Y-0.44%
ROICexc growth 5Y1.03%
OM growth 3Y-3.68%
OM growth 5Y-1.89%
PM growth 3Y-9.69%
PM growth 5Y-1.78%
GM growth 3Y-0.89%
GM growth 5Y0.39%
F-Score5
Asset Turnover1.05
Health
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 5.28
Debt/EBITDA 0.73
Cap/Depr 52.89%
Cap/Sales 4.76%
Interest Coverage 250
Cash Conversion 54.98%
Profit Quality 103.99%
Current Ratio 1.35
Quick Ratio 0.96
Altman-Z N/A
F-Score5
WACC6.08%
ROIC/WACC1.12
Cap/Depr(3y)107.61%
Cap/Depr(5y)100.02%
Cap/Sales(3y)9.74%
Cap/Sales(5y)9.61%
Profit Quality(3y)66.21%
Profit Quality(5y)65.11%
High Growth Momentum
Growth
EPS 1Y (TTM)-30.27%
EPS 3Y-3.83%
EPS 5Y5.12%
EPS Q2Q%-198.51%
EPS Next Y-83.94%
EPS Next 2Y-22.77%
EPS Next 3Y-10.58%
EPS Next 5Y-2.28%
Revenue 1Y (TTM)-1.1%
Revenue growth 3Y6.55%
Revenue growth 5Y7.05%
Sales Q2Q%-4.39%
Revenue Next Year-6.14%
Revenue Next 2Y-2.84%
Revenue Next 3Y-1.13%
Revenue Next 5Y3.18%
EBIT growth 1Y-21.15%
EBIT growth 3Y2.63%
EBIT growth 5Y5.02%
EBIT Next Year-8.38%
EBIT Next 3Y10.55%
EBIT Next 5Y13.3%
FCF growth 1Y431.7%
FCF growth 3Y-8.36%
FCF growth 5Y11.7%
OCF growth 1Y-30.9%
OCF growth 3Y-0.33%
OCF growth 5Y7.21%

DR ING HC F PORSCHE AG / P911.DE FAQ

Can you provide the ChartMill fundamental rating for DR ING HC F PORSCHE AG?

ChartMill assigns a fundamental rating of 5 / 10 to P911.DE.


What is the valuation status of DR ING HC F PORSCHE AG (P911.DE) stock?

ChartMill assigns a valuation rating of 6 / 10 to DR ING HC F PORSCHE AG (P911.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for DR ING HC F PORSCHE AG?

DR ING HC F PORSCHE AG (P911.DE) has a profitability rating of 8 / 10.


Can you provide the PE and PB ratios for P911 stock?

The Price/Earnings (PE) ratio for DR ING HC F PORSCHE AG (P911.DE) is 9.61 and the Price/Book (PB) ratio is 0.76.


How financially healthy is DR ING HC F PORSCHE AG?

The financial health rating of DR ING HC F PORSCHE AG (P911.DE) is 5 / 10.